Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $56.3018 (-0.33%) ($56.2108 - $56.8244) on Thu. May. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 59 | Latest Price | $56.3018(-0.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) SPY(47%) IWD(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.7% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-10%) IGOV(-3%) IPO(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $56.79(-0.86%) | 10 Day Moving Average | $56.18(0.22%) | 20 Day Moving Average | $55.46(1.52%) | To recent high | -2% | To recent low | 20% | Market Cap | $99.332b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |